Psychopharmacology

, Volume 78, Issue 1, pp 38–43 | Cite as

The effect of IV l-tryptophan on prolactin, growth hormone, and mood in healthy subjects

  • Dennis S. Charney
  • George R. Heninger
  • John F. ReinhardJr.
  • David E. Sternberg
  • Karen M. Hafstead
Original Investigations

Abstract

In order to assess the effects of increased CNS serotonergic function in humans on prolactin (PRL), growth hormone (GH), and mood, IV l-tryptophan (TRP) was administered to ten healthy subjects. The TRP infusion induced robust increases in PRL in all ten subjects. A significant increase in GH concentration was also observed, although the response was more variable. The subjects reported feeling significantly more ‘high’, ‘mellow’, and ‘drowsy’ following the TRP infusion in comparison to placebo. These findings indicate an important role for serotonin in PRL and GH secretion, as well as in mood regulation. The IV TRP challenge may be of use in the study of serotonergic function in a variety of neurologic and psychiatric diseases.

Key words

Serotonin Tryptophan Prolactin Growth hormone Mood 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Advis JP, Simpkins G, Meites J (1979) Serotonergic control of prolactin release in male rats. Life Sci 24:359–366Google Scholar
  2. Aprison MH, Takahashi HR, Tachiki K (1978) Hypersensitive serotonin receptors involved in clinical depression: A theory. In: Haber B, Aprison MH (eds) Neuropharmacology and behavior. Plenum, New York, pp 23–53Google Scholar
  3. Arnold MA, Fernstrom JD (1981) l-Tryptophan injection enhances pulsatile growth hormone secretion in the rat. Endocrinology 108:331–335Google Scholar
  4. Beck-Peccoz P, Ferrari C, Rondena M, Paracchi A, Faglia G (1976) Failure of oral 5-hydroxytryptophan to affect prolactin secretion in man. Hormone Res 7:303–307Google Scholar
  5. Birge CA, Jacobs LS, Hammer CT, Daughaday WH (1970) Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. Endocrinology 86:120–130Google Scholar
  6. Briesch ST, Zemlan FP, Hoevel BG (1976) Hyperphagia and obesity following serotonin depletion by intraventricular parachlorophenylalanine. Science 192:382–384Google Scholar
  7. Charney DS, Menkes DB, Heninger GR (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment: Implications for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160–1180Google Scholar
  8. Clemens JA, Roush ME, Fuller RW (1978) Evidence that serotonin neurons stimulate secretion of prolactin-releasing factor. Life Sci 22:2209–2213Google Scholar
  9. Clemens JA, Sawyer BD, Cerimele B (1977) Further evidence that serotonin is a neurotransmitter involved in prolactin secretion. Endocrinology 100:691–698Google Scholar
  10. deMontigny C, Aghajanian G (1978) Tricyclic antidepressants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303–1306Google Scholar
  11. Dorsa DM, Conners MH (1979) Canine growth hormone responsiveness during pentobarbital anaesthesia: A method for evaluating serotonergic stimulatory action. Endocrinology 104:101–106Google Scholar
  12. Eccleston D, Ashcroft GW, Crawford TBB, Stanton JB, Wood D, McTurk PH (1970) Effect of tryptophan administration on 5-HIAA in cerebrospinal fluid in man. J Neurol Neurosurg Psychiatry 33:269–272Google Scholar
  13. Eichelman B (1979) Role of biogenic amines in aggressive behavior. In: Sandler M (ed) Psychopharmacology of aggression. Raven, New York, pp 61–93Google Scholar
  14. Faber J, Hagen C, Kirkegaard C, Lauridsen UB, Muller SE (1977) Lack of effects of l-tryptophan on basal and TRH-stimulated TSH and prolactin levels. Psychoneuroendocrinology 2:413–415Google Scholar
  15. Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173:149–152Google Scholar
  16. Fessler RG, Meltzer HY (1979) Effect of electrolytic lesions of the medial raphe nucleus on 5-HTP- and LU 10-171-induced increases in serum prolactin in rats. Neurosci Abstr 5:1563Google Scholar
  17. Fraser WM, Tucker HS, Grubb SR, Wigand JB, Blackward WG (1979) Effect of l-tryptophan on growth hormone and prolaction release in normal volunteers and patients with secretory pituitary tumors. Horm Metab Res 11:149–155Google Scholar
  18. Friedman E, Dallob A (1979) Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline. Commun Psychopharmacol 3:89–92Google Scholar
  19. Fuxe K, Butcher LL, Engel J (1971) d,l-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol 23:420–424Google Scholar
  20. Fuxe K, Ogren SO, Agnati L, Gustafsson JK, Jonsson G (1977) On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline: Evidence for 5-hydroxytryptamine receptor blocking activity. Neurosci Lett 6:339–344Google Scholar
  21. Garthwaite TL, Hagen TC (1979) Evidence that serotonin stimulates a prolactin-releasing factor in the rat. Neuroendocrinology 29:215–220Google Scholar
  22. Gil-Ad I, Zambohi F, Carruba MO, Vicentini L, Müller EE (1976) Stimulatory role for brain serotonergic system on prolactin secretion in the male rat. Proc Soc Exp Biol Med 151:512–518Google Scholar
  23. Glass AR, Schaaf M, Dimond RC (1979) Absent growth hormone response to l-tryptophan in acromegaly. J Clin Endocrinol Metab 48:664–666Google Scholar
  24. Glass AR, Smallridge RC, Schaaf M, Dimond RC (1980) Absent prolactin response to l-tryptophan in normal and acromegalic subjects. Psychoneuroendocrinology 5:261–265Google Scholar
  25. Green AR, Grahame-Smith DG (1976) Effects of drugs on processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 260:487–491Google Scholar
  26. Greenwood MH, Friedel J, Bond AJ, Curzon G, Lader MH (1974) The acute effects of intravenous infusion of l-tryptophan in normal subjects. Clin Pharmacol Ther 16:455–464Google Scholar
  27. Greenwood MH, Lader MH, Kantameneni BD, Curzon G (1975) The acute effects of oral tryptophan in human subjects. Br J Clin Pharmacol 2:165–172Google Scholar
  28. Handwerger S, Plank JW, Lebovitz HE, Bivens CH, Feldman JM (1979) Failure of 5-hydroxytryptophan to stimulate prolactin and growth hormone secretion on man. Hormon Metab Res 7:214–216Google Scholar
  29. Hyyppa MT, Jolma T, Langvick VA, Kytomaki O, Syvalahti E (1977) l-Tryptophan and neuroendocrine regulation in neurologic patients: Hormone responses to l-tryptophan loading in patients with hypothalamic lesions. Psychoneuroendocrinology 2:349–357Google Scholar
  30. Hyyppa MT, Jolma T, Liira J, Langvick VA, Kytomaki O (1979) l-Tryptophan treatment and the episodic secretion of pituitary hormones and cortisol. Psychoneuroendocrinology 4:29–35Google Scholar
  31. Imura H, Nakai Y, Yoshimi T (1973) Effects of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. J Clin Endocrinol Metab 36:204–206Google Scholar
  32. Jones RSG (1980) Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs. Psychopharmacology 69:307–311Google Scholar
  33. Jouvet M (1969) Biogenic amines and states of sleep. Science 163:32–41Google Scholar
  34. Kamberi IA, Mical RS, Porter JC (1971) Effect of melatonin and serotonin on the release of FSH and prolactin. Endocrinology 88:1288–1293Google Scholar
  35. Kato Y, Nakai Y, Imura H, Kazuo C, Ohgo S (1974) Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man. J Clin Endocrinol Metab 38:695–697Google Scholar
  36. Kordon C, Blake CA, Terkel J, Sawyer CH (1973) Participation of serotonin-containing neurons in the suckling-induced rise in plasma prolactin levels in lactating rats. Neuroendocrinology 13:213–223Google Scholar
  37. Lamberts SWJ, MacLeod RM (1978) The interaction of serotonergic and dopaminergic systems on prolactin secretion in the rat. Endocrinology 103:287–295Google Scholar
  38. Lancranjan I, Wirz-Justice A, Puhringer W, Del Pozo E (1977) Effect of l-5-hydroxytryptophan infusion on growth hormone and prolactin secretion in man. J Clin Endocrinol Metab 45:588–593Google Scholar
  39. Lichtensteiger W, Muntzmer U, Langemann H (1967) Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines. J Neurochem 14:489–497Google Scholar
  40. MacIndoe JH, Turkington RW (1973) Stimulation of human prolactin secretion by intravenous infusion of l-tryptophan. J Clin Invest 52:1972–1978Google Scholar
  41. Maj J, Lewandowska A, Rawlow A (1979) Central antiserotonin action of amitriptyline. Pharmakopsychiatrie 12:281–285Google Scholar
  42. Maj J, Sowinska H, Baran L, Gancarczyk L, Rawlow A (1978) The antiserotonin actions of Mianserin. Psychopharmacology 59:79–84Google Scholar
  43. Meites J, Simpkins J, Bruni J, Advis J (1977) Role of biogenic amines in control of anterior pituitary hormones. IRCS J Med Sci 5:1–7Google Scholar
  44. Meites J, Sonntag WE (1981) Hypothalamis hypophysiotropic hormones and neurotransmitter regulation: Current views. Annu Rev Pharmacol Toxicol 21:295–322Google Scholar
  45. Meltzer HY, Fang VS, Paul SM, Kaluskar R (1976) Effect of quipazine on rat plasma prolactin levels. Life Sci 19:1073–1078Google Scholar
  46. Mendelson WB, Jacobs LS, Reichman JD, Othmer E, Cryer PE, Trivedi B, Daughaday WH (1975) Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion. J Clin Invest 56:690–697Google Scholar
  47. Menkes DB, Aghajanian GK, McCall RB (1980) Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus. Life Sci 27:45–55Google Scholar
  48. Messing RB, Lytle LD (1977) Serotonin-containing neurons: Their possible role in pain and analgesia. Pain 4:1–21Google Scholar
  49. Mogilnicka E, Klimek V (1979) Mianserin, Danitracen and amitriptyline withdrawal increases the behavioral responses of rats to l-5-HTP. J Pharm Pharmacol 31:704Google Scholar
  50. Moit ATB, Eccleston D (1968) The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J Neurochem 15:1093–1108Google Scholar
  51. Mueller GP, Twohy CP, Chen HT, Advis JP, Meites J (1976) Effect of l-tryptophan and restraint stress on hypothalamine and brain serotonin turnover, and pituitary TSH and prolactin release in rats. Life Sci 18:715–724Google Scholar
  52. Muller EE, Brambilla F, Cavagnini F, Peracchi M, Panerai A (1974) Slight effect of l-tryptophan on growth hormone release in normal human subjects. J Clin Endocrinol Metab 39:1–5Google Scholar
  53. Murphy DL, Campell I, Costa JL (1978) Current status of the indoleamine hypothesis of affective disorders. In: Lipton MA, Dimascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Plenum, New York, pp 1235–1247Google Scholar
  54. Myers RD, Yaksh TL (1969) Control of body temperature in the unanesthesized monkey by cholinergic and aminergic systems in the hypothalamus. J Physiol (Lond) 202:483–500Google Scholar
  55. Ng LKY, Chase TN, Colburn RW, Kopin IJ (1972) Release of 3H-dopamine by l-5-hydroxytryptophan. Brain Res 45:499–505Google Scholar
  56. Ogren SO, Fuxe K, Agnati LF, Gustafsson JA, Jonsson G, Holm AC (1979) Reevaluation of the indoleamine hypothesis of depression: Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm 46:85–103Google Scholar
  57. Ohgo SY, Kato Y, Chihara K, Imura H, Maeda K (1976) Effect of hypothalamine surgery on prolactin release induced by 5-hydroxytryptophan (5-HTP) in rats. Endocrinol Jpn 23:485–491Google Scholar
  58. Oswald I, Ashcroft GW, Berger RJ, Eccleston D, Evans JI, Thacore VR (1966) Some experiments in the chemistry of normal sleep. Br J Psychiatry 112:391–399Google Scholar
  59. Peroutka SJ, Snyder SM (1980) Chronic antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88–90Google Scholar
  60. Puhringer W, Wirz-Justice A, Lancranjan I (1976) Mood elevation and pituitary stimulation after IV l-5-HTP in normal subjects: Evidence for a common serotonergic mechanism. Neurosci Lett 2:349–354Google Scholar
  61. Schalch DS, Parker ML (1964) A sensitive double-antibody immunoassay for human growth hormone in plasma. Nature 203:1141–1142Google Scholar
  62. Sinha YA, Selby FW, Lewis VJ, Vanderlaan WP (1973) A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab 36:509–516Google Scholar
  63. Smith B, Prockop DJ (1962) Central nervous system effects of ingestion of l-tryptophan by normal subjects. N Engl J Med 267:1338–1341Google Scholar
  64. Smythe GA, Compton PJ, Lazaru L (1976) Serotonergic control of human growth hormone secretion: The action of l-dopa and 2-bromo-ergocrytise. In: Pecile A, Muller EE (eds) Growth hormone and related peptides. Excerpta Medica, Amsterdam, pp 222–235Google Scholar
  65. Weiner RI, Ganong WF (1978) Monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58:905–976Google Scholar
  66. Woolf PD, Lee L (1977) Effect of serotonin precursor, tryptophan, on pituitary hormone secretion. J Clin Endocrinol Metab 45:123–133Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • Dennis S. Charney
    • 1
  • George R. Heninger
    • 1
  • John F. ReinhardJr.
    • 2
  • David E. Sternberg
    • 1
  • Karen M. Hafstead
    • 1
  1. 1.Department of PsychiatryYale University School of Medicine and Connecticut Mental Health CenterNew HavenUSA
  2. 2.Department of PharmacologyYale University School of Medicine and Connecticut Mental Health CenterNew HavenUSA

Personalised recommendations